STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.;BEIJING STAIDSON MEDICAL TECHNOLOGY CO., LTD.
发明人:
Jianping TAN,Bingzhang WANG
申请号：
US15568450
公开号：
US20180110833A1
申请日:
2016.04.18
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention discloses a nerve growth factor composition and an injection powder comprising a nerve growth factor, a stabilizer, a supporting agent, a pH buffer, water and optionally a surfactant. The stabilizer may be selected from arginine, glutamic acid, glycine and isoleucine. By using an amino acid instead of albumin as a stabilizer, the nerve growth factor composition and the injection powder can avoid the potential risk of viral or other unknown components carried in albumin, ensuring the stability of hNGF and rhNGF during preparation, transportation and storage processes, and allowing for increased safety and quality control.
